نتایج جستجو برای: sustained virological response

تعداد نتایج: 1045619  

Journal: :hepatitis monthly 0
bita behnava iran hepatitis network, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases, baqiyatallah university of medical sciences, tehran, ir iran; middle east liver diseases (meld) center, tehran, ir iran heidar sharafi iran hepatitis network, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases, baqiyatallah university of medical sciences, tehran, ir iran; middle east liver diseases (meld) center, tehran, ir iran; armin pathobiology laboratory, tehran, ir iran maryam keshvari iran hepatitis network, tehran, ir iran; blood transfusion research center, high institute for research and education in transfusion medicine, tehran, ir iran ali pouryasin iran hepatitis network, tehran, ir iran; armin pathobiology laboratory, tehran, ir iran; department of biology, arsanjan branch, islamic azad university, arsanjan, ir iran leila mehrnoush iran hepatitis network, tehran, ir iran; middle east liver diseases (meld) center, tehran, ir iran shima salimi iran hepatitis network, tehran, ir iran; middle east liver diseases (meld) center, tehran, ir iran

patients and methods this cross - sectional study was conducted on 143 thalassemic patients with chronic hepatitis c, who were treated with a combination of peg-ifn and rbv regimen. the rs12979860 and rs8099917 polymorphisms were assessed as the most common polymorphisms near the il28b gene by the polymerase chain reaction-restriction fragment length polymorphism (pcr-rflp) method. objectives w...

Journal: :P & T : a peer-reviewed journal for formulary management 2012
Walter Alexander

A phase 2 study of an interferon-free combination daclatasvir (BMS-790052, Bristol-Meyers Squibb) plus GS-7977 (formerly PSI-7977, Pharmasset/Gilead), with or without ribavirin, showed that this regimen was well tolerated and that treatmentnaive patients with hepatitis C virus (HCV) genotype 1, 2, and 3 infection achieved high rates of early sustained virological responses (SVRs). Investigators...

2009
Pietro Lampertico Alessio Aghemo Mauro Viganò Massimo Colombo

One year of interferon therapy inhibits HBV replication in one third of the patients whereas long-term administration of oral nucleos(t)ide analogues is efficient in most of them, as long as early treatment adaptation in patients with partial virological response and resistance is provided. Following the demonstration of a more potent antiviral effect in terms of sustained virological response ...

Journal: :Antiviral therapy 2010
Jean-Michel Petit Fabrice Carrat Michel Duong Philippe Halfon Laurence Duvillard Firouzé Bani-Sadr Pascal Chavanet Patrice Cacoub Lionel Piroth

BACKGROUND Because high serum low-density lipoprotein (LDL) and total cholesterol concentrations before treatment have been found to be significant positive prognostic factors for a sustained virological response to HCV therapy in monoinfected patients, the aim of this study was to assess this relationship in HIV-HCV-coinfected patients. METHODS Pretreatment fasting lipid parameters (in parti...

2015
Hiromitsu Kumada Kazuaki Chayama Lino Rodrigues Fumitaka Suzuki Kenji Ikeda Hidenori Toyoda Ken Sato Yoshiyasu Karino Yasushi Matsuzaki Kiyohide Kioka Carolyn Setze Tami Pilot‐Matias Meenal Patwardhan Regis A. Vilchez Margaret Burroughs Rebecca Redman

UNLABELLED GIFT-I is a phase 3 trial evaluating the efficacy and safety of a 12-week regimen of coformulated ombitasvir (OBV)/paritaprevir (PTV)/ritonavir (r) for treatment of Japanese hepatitis C virus genotype 1b-infected patients. It consists of a double-blind, placebo-controlled substudy of patients without cirrhosis and an open-label substudy of patients with compensated cirrhosis. Patient...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید